Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Cannabidiol,Tetrahydrocannabinol
Therapeutic Area : Neurology
Study Phase : Approved FDF
Sponsor : Branded Legacy
Deal Size : Undisclosed
Deal Type : Acquisition
Branded Legacy Expands Portfolio with Sycamore BioPharma Acquisition
Details : The acquisition expands Branded Legacy's portfolio ranging from gummies to compression sleeves and topical creams, including Relief Gummy, which contains a balanced ratio of CBD to Nano Delta-9-THC.
Product Name : Relief Gummy
Product Type : Controlled Substance
Upfront Cash : Undisclosed
December 03, 2024
Lead Product(s) : Cannabidiol,Tetrahydrocannabinol
Therapeutic Area : Neurology
Highest Development Status : Approved FDF
Sponsor : Branded Legacy
Deal Size : Undisclosed
Deal Type : Acquisition